Aptamers Market, by Type (Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers and XNA-Based Aptamers) and Peptide Aptamers), by Application (Diagnostics, Therapeutics, and Research and Development), by End User (Biotechnology and Pharmaceutical

Aptamers Market, by Type (Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers and XNA-Based Aptamers) and Peptide Aptamers), by Application (Diagnostics, Therapeutics, and Research and Development), by End User (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Aptamers are revolutionizing the healthcare industry by providing the affinity towards a desired target with high selectivity and specificity. This has led research scientists to gain interest in the field of aptamers with increasing support from public-private organizations. Companies such as Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, and SomaLogic, Inc. are collaborating with each other or independent research organizations and institutes to speed-up the research activities for the treatment of a number of diseases in order to decrease the time to market (TTM).
Market Dynamics
Aptamers offer significant advantages in comparison with protein therapeutics in terms of synthetic accessibility, size, and modification by medicinal chemistry which would aid the development of effective therapies. Continuous investments and development of novel aptamers by market players is expected to propel the market growth over the forecast period. Ophthotech is developing novel therapeutics, Fovista and Zimura (an aptamers), to treat eye diseases. Furthermore, advancements in Systemic Evolution of Ligands by Exponential Enrichment (SELEX) process to extract high-quality aptamers for a more diverse range of applications and government support in developed regions are projected to fuel utilization of these products, leading to market growth.
Key features of the study:
This report provides in-depth analysis of the global aptamers market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global aptamers market based on the following parameters: company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
Key players covered as a part of this study include Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies and Vivonics Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global aptamers market report caters to various stakeholders in this industry, which include investors, product manufacturers, distributors, and suppliers for global aptamers market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Aptamers Market, by Type:
Nucleic Acid Aptamers
DNA-Based Aptamers
RNA-Based Aptamers
XNA-Based Aptamers
Peptide Aptamers
Global Aptamers Market, by Application:
Diagnostics
Therapeutics
Research and Development
Global Aptamers Market, by End User:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization
Global Aptamers Market, by Region:
North America
By Country:
U.S.
Canada
By Type:
Nucleic Acid Aptamers
DNA-Based Aptamers
RNA-Based Aptamers
XNA-Based Aptamers
Peptide Aptamers
By Application:
Diagnostics
Therapeutics
Research and Development
By End User:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Type:
Nucleic Acid Aptamers
DNA-Based Aptamers
RNA-Based Aptamers
XNA-Based Aptamers
Peptide Aptamers
By Application:
Diagnostics
Therapeutics
Research and Development
By End User:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Type:
Nucleic Acid Aptamers
DNA-Based Aptamers
RNA-Based Aptamers
XNA-Based Aptamers
Peptide Aptamers
By Application:
Diagnostics
Therapeutics
Research and Development
By End User:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Type:
Nucleic Acid Aptamers
DNA-Based Aptamers
RNA-Based Aptamers
XNA-Based Aptamers
Peptide Aptamers
By Application:
Diagnostics
Therapeutics
Research and Development
By End User:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Type:
Nucleic Acid Aptamers
DNA-Based Aptamers
RNA-Based Aptamers
XNA-Based Aptamers
Peptide Aptamers
By Application:
Diagnostics
Therapeutics
Research and Development
By End User:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Type:
Nucleic Acid Aptamers
DNA-Based Aptamers
RNA-Based Aptamers
XNA-Based Aptamers
Peptide Aptamers
By Application:
Diagnostics
Therapeutics
Research and Development
By End User:
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization
Company Profiles
Ophthotech Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Aptamer Sciences, Inc.
Novartis AG
SomaLogic, Inc.
NeoNeuro SAS
Aptagen, LLC
Aptus Biotech S.L.
AM Biotechnologies, LLC
Base Pair Biotechnologies
Vivonics Inc.
“*” marked represents similar segmentation in other categories in the respective section.